Kinetics of C-reactive protein release in different forms of acute coronary syndrome;Cinética de la proteína C reactiva en las distintas manifestaciones clínicas del síndrome coronario agudo

Revista Espanola de Cardiologia

Volumn 59, Issue 5, 2006, Pages 441-447

  Sánchez, Pedro L ^a   Rodríguez, María V ^b   Villacorta, Eduardo ^a   Albarrán, Carmen ^b   Cruz, Ignacio ^b   Moreiras, Javier M ^b   Martín, Francisco ^b   Pabón, Pedro ^b   Fernández Avilés, Francisco ^a   Martín Luengo, Cándido ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

C reactive protein; Inflammation; Myocardial infarction; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; UNSTABLE ANGINA PECTORIS;

EID: 33745295944     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13087896     Document Type: Article

References (25)

1. Ross P. Atherosclerosis - An inflammatory disease. N Engl J Med. 1999;340:115-26.
2. García-Moll X, Kaski JC. Cardiopatá isquémica: marcadores de inflamación y riesgo cardiovascular. Rev Esp Cardiol. 1999;52: 990-1003.
3. Angiolillo DJ, Biasucci LM, Liuzzo G, Crea F. La inflamación en los síndromes coronarios agudos: mecanismos e implicaciones clínicas. Rev Esp Cardiol. 2004;57:433-46.
4. Mo VY, De Lemos JA. Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy. Curr Cardiol Rep. 2004;6:273-8.
5. Sanchís J, Bodí V, Llàcer Á, Facila L, Martínez-Brotons A, Insa L, et al. Relación de los valores de proteína C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2004;57:382-7.
6. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation. 2004;110:1747-53.
7. Avanzas P, Arroyo-Espliguero P, Cosín-Sales J, Aldama G, Pizzi C, Quiles J, et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart. 2004;90: 847-52.
8. Arroyo-Espliguero R, Avanzas P, Kaski JC. Enfermedad cardiovascular aterosclerótica: la utilidad de la proteína C reactiva en la identificación de la placa «vulnerable» y del paciente «vulnerable» Rev Esp Cardiol. 2004;57:375-8.
9. Arroyo-Espliguero P, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart 2004;25:401-8.
10. Zairis MN, Lyras AG, Bibis GP, Patsourakos NG, Makrygiannis SS, Kardoulas AD, et al. Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction. Atherosclerosis. 2005;182:161-7.
11. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350-1387-97.
12. De Winter RJ, Fischer JC, De Jongh T, Van Straalen JP, Bholasingh R, Sanders GT. Different time frames for the occurrence of elevated levels of cardiac troponin T and C-reactive protein in patients with acute myocardial infarction. Clin Chem Lab Med. 2000;38:1151-3.
13. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore JR, Galigiuri G, Lanza GA, et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation. 1996;94: 2373-80.
14. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-69.
15. Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410-4.
16. Sánchez PL, Moriñigo JL, Pabón P, Martín F, Piedra I, Palacios IF, et al. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome. Heart. 2004;90;264-9.
17. Vollmer RT, Christenson RH, Reimer K, Ohman EM. Temporal creatine kinase curves in acute myocardial infarction: implications of a good empiric fit with the log-normal function. Am J Clin Pathol. 1993;100:293-8.
18. Arós F, Cunat J, Loma-Osorio A, Torrado E, Bosch X, Rodríguez JJ, et al. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol. 2003;56:1165-73.
19. Schroder R, Dissmann R, Bruggemann T, Wegscheider K, Linderer T, Tebbe U, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol. 1994;24:384-91.
20. Liuzzo G, Biasucci LM, Rebuzzi AG, Gallimore JR, Caligiuri G, Lanza GA, et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation. 1996;94: 2373-80.
21. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347:5-12.
22. Bazzino O, Fuselli JJ, Botto F, Pérez De Arenaza D, Bahit C, Dadone J; PACS group of investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes. Eur Heart J. 2004; 25:859-66.
23. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 1996;17:1345-9.
24. Zairis MN, Manousakis SJ, Stefanidis AS, Papadaki OA, Andrikopoulos GK, Olympios CD, et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J. 2002;144:782-9.
25. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855-60.